February 28, 2021

Day: November 30, 2020

PRESS RELEASES

Sinch AB (publ): Sinch announces its intention to carry out a directed new share issue and large shareholders’ intention to sell existing shares to a fund managed by SB Management

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA, NEW ZEALAND, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE MAY BE UNLAWFUL, WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES Press Release Stockholm, 30 November […]

Read More
PRESS RELEASES

Philips expands its healthcare customer services portfolio with the introduction of integrated Cybersecurity Services

November 30, 2020 Philips partners with CyberMDX, a leader in connected medical device security, to provide vendor-neutral solutions to protect connected medical systems and devices Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of the Philips Cybersecurity Services for seamlessly integrating and enhancing strategic security solutions […]

Read More
PRESS RELEASES

Philips introduces next generation of Advanced Visualization Workspace – IntelliSpace Portal 12 – with AI capabilities at RSNA 2020

November 30, 2020 Next generation of Philips’ advanced radiology visualization platform leverages image post-processing and artificial intelligence (AI) to deliver quantitative clinical insights, drive increased diagnostic confidence, simplify workflows, and reduce time-to-report New features include AI algorithms for lung nodule detection, cardiac functional analysis, and quantification of pulmonary infiltrates associated with COVID-19 patients Intelligent, automated […]

Read More
PRESS RELEASES

Algernon Pharmaceuticals Announces Enrollment of Final Patient in its Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19

VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that the final patient has been enrolled in its multinational Phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19. The aggregate […]

Read More
PRESS RELEASES

Novavax Announces COVID-19 Vaccine Clinical Development Progress

Pivotal Phase 3 trial in United Kingdom completes enrollment Phase 2b efficacy trial in South Africa completes enrollment U.S./Mexico Phase 3 trial expected to begin in the coming weeks GAITHERSBURG, Md., Nov. 30, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided an update […]

Read More
Miscellaneous

Eight New COVID-19 Cases Recorded; Tally 323

Cambodia’s Ministry of Health this morning announced eight new cases of the novel coronavirus (COVID-19); the tally thus rose to 323. According to ministry’s press release, the new cases are all Cambodians living in Phnom Penh, of them five women, two men and a child. They are all related to the Nov. 28 Community Event […]

Read More